securities fraud

Robbins LLP reminds investors of May 18, 2026 deadline to join class action against Concorde International Group ($CIGL) over alleged pump-and-dump scheme using social media misinformation.

Super Micro Computer faces class action lawsuit alleging concealment of Chinese customer sales in violation of U.S. export controls. Lead plaintiff deadline is May 26, 2026.

Law firm Robbins LLP urges $PSIX investors to act by May 19, 2026 deadline in class action alleging misleading data center projections and hidden manufacturing issues.

Law firm sues Franklin BSP Realty Trust ($FBRT) for allegedly overstating prospects and dividend sustainability. Investors can join as lead plaintiffs by April 27, 2026.

Four public companies face securities fraud class actions alleging misrepresentations in operational performance, clinical trials, and financial reporting. Lead plaintiff deadlines: May 5-8, 2026.

ADMA Biologics faces securities fraud investigation for alleged channel stuffing, resulting in 29.1% stock decline to $9.63 per share.

Corcept Therapeutics shares crashed 50% after FDA rejected relacorilant application. Class action lawsuit alleges company concealed prior FDA warnings about clinical development concerns.

Trip.com faces securities fraud lawsuit over concealed antitrust investigation. Stock fell 17% when probe was disclosed.

Securities fraud investigation launched into $GEMI following 79% stock collapse from $28 IPO price to $5.96 after February 2026 strategic pivot announcement.

ODDITY Tech stock crashes 49% after disclosing algorithm changes by major ad partner will slash Q1 revenue 30%. Securities fraud lawsuit filed by shareholders.

Class action lawsuit alleges $PSIX made false statements about data center demand and understated manufacturing costs, covering May 2025-March 2026 investors.

Class action lawsuit filed against Kyndryl for alleged false financial statements and internal control failures during August 2024-February 2026 period.

Class action lawsuit filed against PayPal alleging executives made false statements about revenue projections and 2027 targets under CEO James Chriss.

Class action lawsuit filed against $ENPH alleging overstatement of inventory management and tax credit mitigation capabilities. Lead plaintiff deadline set for April 20, 2026.

Class action lawsuit filed against $ATARAWITH alleging executives made false statements about manufacturing issues and ALLELE study deficiencies that could block FDA approval of tabelecleucel.

Portnoy Law Firm launches securities fraud investigation into Abacus Global over alleged inflated life expectancy data. Stock drops 21.5% to $6.00 per share.

Law firm investigates JFrog for possible securities fraud after 27.5% stock decline triggered by slashed guidance and weak cloud revenue growth.

Portnoy Law Firm sues Apollo Global Management over undisclosed Epstein communications, citing material misrepresentations to investors during 2021-2026 period; stock fell 5-6% post-disclosure.

Portnoy Law Firm investigates $HUBG for potential securities fraud following 27% stock decline tied to disclosed accounting errors and control failures.

Portnoy Law Firm files class action lawsuit against Boston Scientific for allegedly misleading investors about growth prospects and competitive pressures in electrophysiology market.